Table 1.
Demographic and clinical features at the admission.
| Variables | COVID-19 | Non–COVID-19 | MIS-C |
|---|---|---|---|
| Number of patients | 68 | 16 | 4 |
| Age | |||
| Median years (IQR) | 6.5 (0.9–11.5) | 4.4 years (1.7–6.3) | 11.7 years (10.5–12.8) |
| Min | 8 days | 1 years | 8 years |
| Max | 17 years | 16 years | 14.5 |
| Sex | |||
| Male | 38 (56%) | 10 (53%) | 3 (75%) |
| Comorbidities | 4 (6%) | 5 (26%) | 1 (25%) |
| Symptoms at the admission | |||
| Fever | 36 (56%) | 15 (79%) | 4 (100%) |
| Respiratory symptoms | |||
| Cough | 18 (27%) | 5 (26.3%) | 0 |
| Shortness of breath | 7 (10%) | 0 | 0 |
| Rhinorrhea | 2 (3%) | 1 (5.2%) | 0 |
| Gastrointestinal symptoms | |||
| Diarrhea | 11 (16%) | 4 | 1 (25%) |
| Vomit | 3 (4%) | 1 | 1 (25%) |
| Disease severity | |||
| Asymptomatic | 12 (18%) | NA | NA |
| Mild | 49 (72%) | NA | NA |
| Moderate | 7 (10%) | NA | NA |
| Blood result | |||
| Lymphopenia | 11 (22%) | 1(5.2%) | 2 (50%) |
| C reactive protein, median, mg/dl | 0.09 | 4.81 | 6 |
| Radiological results | |||
| Suggestive of viral pneumonia | 7 (10%) | NA | NA |
| Coinfection | |||
| Viral coinfection | 1 (HHV6) | NA | NA |
| Bacterial coinfection | 4 (6%) | NA | NA |
| Antibiotic use | 18 (26%) | 10 (63%) | 4 (100%) |